ALGORAE PHARMACEUTICALS LIMITED — Director's Dealing 2007

Aug 23, 2007

Appendix 3Z Final Director’s Interest Notice

Rule 3.19A.3

Appendix 3Z

Final Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity LIVING CELL TECHNOLOGIES LTD ACN 104 028 042

We (the entity) give ASX the following information under listing rule 3.19A.3 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of director MR CHARLES MACEK

Date of last notice 7 June 2007

Date that director ceased to be director 24 August 2007

Part 1 – Director’s relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

150,000 OPTIONS EXERCISABLE AT $0.20 EACH, VESTING ON 16 MARCH 2007 AND EXPIRING ON 1 JUNE 2012 HELD BY CHARLES MACEK

250,000 OPTIONS EXERCISABLE AT $0.30 EACH, VESTING ON 16 MARCH 2007 AND EXPIRING ON 1 JUNE 2012 HELD BY CHARLES MACEK

• See chapter 19 for defined terms.

Appendix 3Z Page 1

11/3/2002

Appendix 3Z Final Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of interestNote: Provide details of the circumstances giving rise tothe relevant interestHELD BY KATHMANDUINVESTMENTS ATFEXCALIBUR NATIONALPRIVATE SUPERFUND	Number & class of securities328,571 ORDINARY SHARES

Part 3 – Director’s interests in contracts

Detail of contract	N/A
Nature of interest
Name of registered holder(if issued securities)
No. and class of securities to whichinterest relates

• See chapter 19 for defined terms.

Appendix 3Z Page 2

11/3/2002